<!DOCTYPE html><html lang="en"><head><meta charset="UTF-8"><meta name="viewport" content="width=device-width,initial-scale=1"><title>SyloraQ Software License Agreement 2025</title><style>@import url(https://fonts.googleapis.com/css2?family=Orbitron:wght@400;700;900&family=Exo+2:wght@300;400;600&display=swap);*{margin:0;padding:0;box-sizing:border-box}:root{--primary-cyan:#00ffff;--primary-purple:#8b5cf6;--primary-pink:#ec4899;--dark-bg:#0a0a0f;--card-bg:rgba(15, 15, 30, 0.8);--glass-bg:rgba(255, 255, 255, 0.05);--text-light:#e2e8f0;--text-dim:#94a3b8;--accent-gold:#fbbf24;--warning-red:#ef4444}body{font-family:'Exo 2',sans-serif;background:var(--dark-bg);color:var(--text-light);line-height:1.6;overflow-x:hidden}.bg-animation{position:fixed;top:0;left:0;width:100%;height:100%;z-index:-1;background:linear-gradient(45deg,var(--dark-bg) 0,#1a0b2e 25%,#16213e 50%,#0f3460 75%,var(--dark-bg) 100%);animation:gradientShift 8s ease-in-out infinite}.bg-animation::before{content:'';position:absolute;top:0;left:0;width:100%;height:100%;background-image:radial-gradient(circle at 25% 25%,rgba(0,255,255,.1) 0,transparent 50%),radial-gradient(circle at 75% 75%,rgba(236,72,153,.1) 0,transparent 50%),radial-gradient(circle at 50% 50%,rgba(139,92,246,.1) 0,transparent 50%);animation:floatOrbs 12s ease-in-out infinite}@keyframes gradientShift{0%,100%{background-position:0 50%}50%{background-position:100% 50%}}@keyframes floatOrbs{0%,100%{transform:translate(0,0) rotate(0)}33%{transform:translate(30px,-30px) rotate(120deg)}66%{transform:translate(-20px,20px) rotate(240deg)}}.header{position:relative;text-align:center;padding:4rem 2rem;background:linear-gradient(135deg,var(--glass-bg),rgba(0,255,255,.05));backdrop-filter:blur(20px);border-bottom:1px solid rgba(0,255,255,.2)}.header::before{content:'';position:absolute;top:0;left:0;right:0;height:2px;background:linear-gradient(90deg,transparent,var(--primary-cyan),var(--primary-purple),var(--primary-pink),transparent);animation:scanLine 3s linear infinite}@keyframes scanLine{0%{transform:translateX(-100%)}100%{transform:translateX(100%)}}.logo{font-family:Orbitron,monospace;font-size:3.5rem;font-weight:900;background:linear-gradient(45deg,var(--primary-cyan),var(--primary-purple),var(--primary-pink));-webkit-background-clip:text;background-clip:text;-webkit-text-fill-color:transparent;text-shadow:0 0 30px rgba(0,255,255,.3);animation:glow 2s ease-in-out infinite alternate}@keyframes glow{from{filter:brightness(1)}to{filter:brightness(1.2) drop-shadow(0 0 20px rgba(0, 255, 255, .4))}}.subtitle{font-size:1.2rem;margin-top:1rem;color:var(--text-dim);font-weight:300}.effective-date{margin-top:2rem;padding:1rem 2rem;background:var(--glass-bg);border:1px solid rgba(0,255,255,.3);border-radius:50px;display:inline-block;font-family:Orbitron,monospace}.toc{background:var(--card-bg);border-radius:20px;border:1px solid rgba(0,255,255,.1);padding:2rem;margin:2rem 0;backdrop-filter:blur(10px)}.toc-title{font-family:Orbitron,monospace;font-size:1.5rem;color:var(--primary-cyan);margin-bottom:1.5rem;text-align:center}.toc-grid{display:grid;grid-template-columns:repeat(auto-fit,minmax(300px,1fr));gap:1rem}.toc-item{padding:.8rem 1rem;background:rgba(139,92,246,.1);border:1px solid rgba(139,92,246,.3);border-radius:10px;cursor:pointer;transition:all .3s ease;text-decoration:none;color:var(--text-light);display:flex;align-items:center;gap:1rem}.toc-item:hover{background:rgba(139,92,246,.2);border-color:var(--primary-purple);transform:translateX(10px)}.toc-number{background:var(--primary-purple);padding:.3rem .8rem;border-radius:20px;font-family:Orbitron,monospace;font-size:.9rem;min-width:2.5rem;text-align:center}.progress-container{position:fixed;top:0;left:0;width:100%;height:3px;background:rgba(0,0,0,.5);z-index:1000}.progress-bar{height:100%;background:linear-gradient(90deg,var(--primary-cyan),var(--primary-purple),var(--primary-pink));width:0%;transition:width .3s ease}.container{max-width:1200px;margin:0 auto;padding:2rem}.section{margin:3rem 0;padding:2rem;background:var(--card-bg);border-radius:20px;border:1px solid rgba(0,255,255,.1);backdrop-filter:blur(10px);position:relative;overflow:hidden;transition:transform .3s ease}.section::before{content:'';position:absolute;top:0;left:-100%;width:100%;height:2px;background:linear-gradient(90deg,transparent,var(--primary-cyan),transparent);transition:left .6s ease}.section:hover::before{left:100%}.section:hover{transform:translateY(-5px)}.section-title{font-family:Orbitron,monospace;font-size:1.8rem;font-weight:700;margin-bottom:1.5rem;color:var(--primary-cyan);display:flex;align-items:center;gap:1rem}.section-number{background:linear-gradient(45deg,var(--primary-purple),var(--primary-pink));padding:.5rem 1rem;border-radius:10px;font-size:1rem;min-width:3rem;text-align:center}.subsection{margin:1.5rem 0;padding-left:1rem;border-left:2px solid rgba(139,92,246,.3)}.subsection-title{font-weight:600;color:var(--accent-gold);margin-bottom:.5rem}.interactive-definition{background:rgba(0,255,255,.05);border:1px solid rgba(0,255,255,.2);border-radius:10px;padding:1rem;margin:1rem 0;cursor:pointer;transition:all .3s ease}.interactive-definition:hover{background:rgba(0,255,255,.1);border-color:var(--primary-cyan);transform:translateX(10px)}.definition-term{font-weight:700;color:var(--primary-cyan);font-family:Orbitron,monospace}.code-block{background:rgba(0,0,0,.5);border:1px solid rgba(0,255,255,.3);border-radius:15px;padding:2rem;margin:2rem 0;font-family:'Courier New',monospace;overflow-x:auto;position:relative}.code-block::before{content:'< CODE />';position:absolute;top:10px;right:15px;font-size:.8rem;color:var(--primary-cyan);opacity:.7}.warning-box{background:linear-gradient(135deg,rgba(236,72,153,.1),rgba(139,92,246,.1));border:2px solid var(--primary-pink);border-radius:15px;padding:1.5rem;margin:2rem 0;position:relative}.warning-box::before{content:'âš ';position:absolute;top:-10px;left:20px;background:var(--dark-bg);padding:0 10px;font-size:1.5rem;color:var(--primary-pink)}.critical-box{background:linear-gradient(135deg,rgba(239,68,68,.1),rgba(236,72,153,.1));border:2px solid var(--warning-red);border-radius:15px;padding:1.5rem;margin:2rem 0;position:relative;animation:pulse 2s infinite}.critical-box::before{content:'ðŸš¨';position:absolute;top:-10px;left:20px;background:var(--dark-bg);padding:0 10px;font-size:1.5rem}@keyframes pulse{0%,100%{box-shadow:0 0 10px rgba(239,68,68,.3)}50%{box-shadow:0 0 20px rgba(239,68,68,.6)}}ol,ul{margin-left:2rem;margin-top:1rem}li{margin-bottom:.5rem;padding-left:.5rem}.checklist{background:rgba(139,92,246,.05);border-radius:15px;padding:2rem;margin:2rem 0}.checklist-item{display:flex;align-items:center;gap:1rem;padding:.5rem 0;transition:all .3s ease;cursor:pointer}.checklist-item:hover{background:rgba(139,92,246,.1);border-radius:8px;padding-left:1rem}.checkbox{width:20px;height:20px;border:2px solid var(--primary-purple);border-radius:4px;display:flex;align-items:center;justify-content:center;transition:all .3s ease}.checkbox:hover{background:var(--primary-purple);transform:scale(1.1)}.eula-section{background:linear-gradient(135deg,rgba(0,255,255,.05),rgba(139,92,246,.05));border:2px solid var(--primary-cyan);border-radius:20px;padding:2rem;margin:3rem 0}.scroll-top{position:fixed;bottom:2rem;right:2rem;width:60px;height:60px;background:linear-gradient(45deg,var(--primary-cyan),var(--primary-purple));border:none;border-radius:50%;cursor:pointer;display:flex;align-items:center;justify-content:center;font-size:1.5rem;color:#fff;opacity:0;visibility:hidden;transition:all .3s ease;box-shadow:0 5px 20px rgba(0,255,255,.3)}.scroll-top.visible{opacity:1;visibility:visible}.scroll-top:hover{transform:translateY(-5px) scale(1.1);box-shadow:0 10px 30px rgba(0,255,255,.5)}@media (max-width:768px){.logo{font-size:2.5rem}.container{padding:1rem}.section{padding:1.5rem}.toc-grid{grid-template-columns:1fr}}</style></head><body><div class="bg-animation"></div><div class="progress-container"><div class="progress-bar" id="progressBar"></div></div><header class="header"><h1 class="logo">SyloraQ</h1><p class="subtitle">SOFTWARE LICENSE AGREEMENT</p><div class="effective-date">2025</div><p style="margin-top:1rem;opacity:.8"></p></header><main class="container"><div class="toc"><h2 class="toc-title">TABLE OF CONTENTS</h2><div class="toc-grid"><a href="#definitions" class="toc-item"><span class="toc-number">1</span><span>Definitions</span></a><a href="#grant" class="toc-item"><span class="toc-number">2</span><span>Grant of License</span></a><a href="#permitted" class="toc-item"><span class="toc-number">3</span><span>Permitted Uses</span></a><a href="#prohibitions" class="toc-item"><span class="toc-number">4</span><span>Prohibitions</span></a><a href="#dependencies" class="toc-item"><span class="toc-number">5</span><span>Third-Party Dependencies</span></a><a href="#attribution" class="toc-item"><span class="toc-number">6</span><span>Attribution & Trademark</span></a><a href="#warranty" class="toc-item"><span class="toc-number">7</span><span>Warranty, Title & Risk</span></a><a href="#liability" class="toc-item"><span class="toc-number">8</span><span>Limitation of Liability</span></a><a href="#indemnification" class="toc-item"><span class="toc-number">9</span><span>Indemnification</span></a><a href="#termination" class="toc-item"><span class="toc-number">10</span><span>Termination & Protection Revocation</span></a><a href="#chain-protection" class="toc-item"><span class="toc-number">11</span><span>Chain-Protection & Enforcement</span></a><a href="#audits" class="toc-item"><span class="toc-number">12</span><span>Audits & Compliance</span></a><a href="#privacy" class="toc-item"><span class="toc-number">13</span><span>Data Privacy & Security</span></a><a href="#export" class="toc-item"><span class="toc-number">14</span><span>Export Controls</span></a><a href="#high-risk" class="toc-item"><span class="toc-number">15</span><span>High-Risk Use</span></a><a href="#severability" class="toc-item"><span class="toc-number">16</span><span>Severability</span></a><a href="#governing-law" class="toc-item"><span class="toc-number">17</span><span>Governing Law</span></a><a href="#notices" class="toc-item"><span class="toc-number">18</span><span>Notices</span></a><a href="#signature" class="toc-item"><span class="toc-number">19</span><span>Signature</span></a></div></div><section id="definitions" class="section"><h2 class="section-title"><span class="section-number">1</span>DEFINITIONS</h2><div class="interactive-definition"><div class="definition-term">1.1 "Software"</div><p>All components provided by SyloraQ, including binary and source code, libraries, scripts, configuration files, build artifacts, examples, documentation, installers, containers, APIs, and related materials.</p></div><div class="interactive-definition"><div class="definition-term">1.2 "Licensee" / "You"</div><p>The individual or legal entity granted rights under this Agreement.</p></div><div class="interactive-definition"><div class="definition-term">1.3 "Private Use"</div><p>Use strictly within Licensee's organization by employees or contractors authorized under confidentiality obligations, on devices and infrastructure controlled by Licensee. Private Use excludes any third-party distribution, remote public access, or exposure to external users.</p></div><div class="interactive-definition"><div class="definition-term">1.4 "Public Use"</div><p>Any use that exposes the Software to third parties â€” including distribution, embedding into public products or services, cloud hosting, container images, API endpoints, repositories, or any publicly accessible system.</p></div><div class="interactive-definition"><div class="definition-term">1.5 "Modification"</div><p>Any alteration, adaptation, translation, patching, compilation, obfuscation, reverse-engineering, decompilation, disassembly, or other change to the Software, and any creation of Derivative Works by any means (including manual, automated, or AI-assisted methods).</p></div><div class="interactive-definition"><div class="definition-term">1.6 "Derivative Work" / "Derivative Program"</div><p>Any work that incorporates or is based upon the Software in whole or in part, including subsequent programs, libraries, modules, services, or outputs that depend upon, are generated from, or are built using the Software or any Derivative Program at any depth of derivation.</p></div><div class="interactive-definition"><div class="definition-term">1.7 "Immediate Creator" / "Immediate User"</div><p>The natural person or legal entity that directly produced, deployed, or distributed a Program or Derivative Program.</p></div><div class="interactive-definition"><div class="definition-term">1.8 "Malicious Use"</div><p>Any use that is intended to or reasonably expected to: (a) damage, disrupt, or compromise systems, networks, data, services, or devices; (b) create malware, ransomware, spyware, exploits, botnets, or similar harmful software; (c) facilitate unauthorized access to systems or data; (d) facilitate fraud, phishing, harassment, or invasion of privacy; or (e) otherwise violate applicable law or accepted security practices.</p></div><div class="interactive-definition"><div class="definition-term">1.9 "Protected Chain"</div><p>The hierarchical tree of Derivative Programs originating from SyloraQ Software where each layer propagates protective and restrictive obligations downstream and receives conditional liability protection upstream.</p></div></section><section id="grant" class="section"><h2 class="section-title"><span class="section-number">2</span>GRANT OF LICENSE</h2><div class="subsection"><h3 class="subsection-title">2.1 License Grant</h3><p>Subject to full compliance with this Agreement, SyloraQ grants Licensee a non-exclusive, worldwide, royalty-free, revocable license to:</p><ul><li>Install, execute, and use the Software on Licensee-controlled devices;</li><li>Embed unmodified Software into Licensee Programs provided the full license text (this Agreement) is attached and propagated as required by Section 11;</li><li>Distribute the Software in object (binary) form only, with required attribution and license propagation;</li><li>Create Derivative Programs only in accordance with this Agreement and only if the Derivative Program enforces the obligations in Sections 3â€“6 and 11.</li></ul></div><div class="subsection"><h3 class="subsection-title">2.2 Reserved Rights</h3><p>All rights not expressly granted are reserved by SyloraQ.</p></div><div class="warning-box"><strong>2.3 Revocability:</strong>The license is revocable by SyloraQ under the terms of Sections 10 and 11.</div></section><section id="permitted" class="section"><h2 class="section-title"><span class="section-number">3</span>PERMITTED USES</h2><div class="subsection"><h3 class="subsection-title">3.1 Personal & Internal Use</h3><p>Use for personal, educational, research, development, testing, and internal business purposes is permitted so long as Licensee enforces the obligations and propagation requirements set forth in Section 11.</p></div><div class="subsection"><h3 class="subsection-title">3.2 Commercial & Public Use</h3><p>Public or commercial deployment is permitted only when Licensee: (a) includes required attribution (Section 6); (b) attaches the full license to distributed artifacts; (c) enforces Malicious Use prohibitions on all downstream users; and (d) complies with Third-Party Dependencies (Section 5) and Export Controls (Section 14).</p></div><div class="subsection"><h3 class="subsection-title">3.3 Cloud / Container / SaaS / AI Use</h3><p>Use in cloud, containerized, hosted, or AI-assisted environments is permitted under the same obligations. Licensee is responsible for access control, security, attribution, and license propagation for hosted endpoints and images.</p></div></section><section id="prohibitions" class="section"><h2 class="section-title"><span class="section-number">4</span>PROHIBITIONS</h2><div class="critical-box"><strong>CRITICAL:</strong>Any Program or Derivative Program that is used to create or distribute malicious software immediately loses all protections under this Agreement (see Section 10).</div><div class="subsection"><h3 class="subsection-title">4.1 No Unauthorized Modification</h3><p>Licensee shall not modify, adapt, or create Derivative Works of the Software except as expressly permitted in writing by SyloraQ or as expressly allowed by law (and only for interoperability if legally required). Any permitted Modification must still comply with propagation and anti-malware rules.</p></div><div class="subsection"><h3 class="subsection-title">4.2 No Reverse Engineering for Circumvention</h3><p>Reverse-engineering, decompilation, disassembly, or other attempts to discover or bypass licensing, security, or attribution mechanisms are prohibited. Reverse-engineering allowed by mandatory law must not be used to evade any license obligation.</p></div><div class="subsection"><h3 class="subsection-title">4.3 No Malicious Use</h3><p>Use of the Software to create, test, distribute, or facilitate malware, ransomware, exploits, automated attacks, or other Malicious Use is strictly prohibited.</p></div><div class="subsection"><h3 class="subsection-title">4.4 No Unauthorized Redistribution</h3><p>Licensee may not sell, lease, sublicense, or otherwise distribute the Software as a standalone product except under terms that fully propagate this Agreement and achieve chain protection as defined in Section 11.</p></div><div class="subsection"><h3 class="subsection-title">4.5 No Circumvention</h3><p>Hiding, obfuscating, or otherwise attempting to evade any obligation of this Agreement (including attribution, propagation, auditing, or conditional protection) is prohibited.</p></div><div class="subsection"><h3 class="subsection-title">4.6 No Use to Violate Law</h3><p>The Software shall not be used to commit unlawful acts or to assist others in doing so.</p></div></section><section id="dependencies" class="section"><h2 class="section-title"><span class="section-number">5</span>THIRD-PARTY DEPENDENCIES</h2><div class="subsection"><h3 class="subsection-title">5.1 Acknowledgement & Compliance</h3><p>The Software may include or rely upon third-party components subject to separate licenses. Licensee must comply with those terms. Noncompliance constitutes a material breach of this Agreement.</p></div><div class="subsection"><h3 class="subsection-title">5.2 Notice Requirement</h3><p>When distributing Derivative Programs, Licensee must include or reference all applicable third-party license notices and attributions required by those components.</p></div></section><section id="attribution" class="section"><h2 class="section-title"><span class="section-number">6</span>ATTRIBUTION & TRADEMARK</h2><div class="subsection"><h3 class="subsection-title">6.1 Attribution Required</h3><p>For any Public Use or distribution, Licensee must include the following attribution in a prominent place (e.g., UI footer, About page, product documentation, or README):</p><div class="code-block">"This product uses software developed by SyloraQ Â© 2025."</div></div><div class="subsection"><h3 class="subsection-title">6.2 Trademark Use</h3><p>Use of the SyloraQÂ® name or logo is permitted only to accurately identify origin and must not imply endorsement. Any use suggesting endorsement requires prior written permission and compliance with SyloraQ's trademark guidelines.</p></div><div class="subsection"><h3 class="subsection-title">6.3 Propagation of Attribution</h3><p>Attribution must propagate with any distributed Derivative Program and be included in any End-User License Agreement (EULA) or terms presented to downstream users.</p></div></section><section id="warranty" class="section"><h2 class="section-title"><span class="section-number">7</span>WARRANTY, TITLE & RISK</h2><div class="subsection"><h3 class="subsection-title">7.1 As-Is</h3><p>The Software is provided "as is," "as available," without warranties of any kind, express or implied, including merchantability, fitness for a particular purpose, or non-infringement.</p></div><div class="subsection"><h3 class="subsection-title">7.2 Title</h3><p>SyloraQ represents that it has the rights necessary to license the Software.</p></div><div class="subsection"><h3 class="subsection-title">7.3 User Responsibility</h3><p>Licensee is solely responsible for determining suitability of the Software for Licensee's purposes and for compliance with applicable law.</p></div><div class="subsection"><h3 class="subsection-title">7.4 Data Protection</h3><p>If the Software processes personal data, Licensee is responsible for compliance with applicable data protection laws (e.g., GDPR, CCPA) and for obtaining any necessary consents or legal bases.</p></div><div class="subsection"><h3 class="subsection-title">7.5 No Monitoring</h3><p>SyloraQ does not undertake proactive monitoring of Licensee's use. Malicious acts or misuse are the sole responsibility of the Immediate Creator(s) as provided in Sections 9â€“11.</p></div></section><section id="liability" class="section"><h2 class="section-title"><span class="section-number">8</span>LIMITATION OF LIABILITY</h2><div class="subsection"><h3 class="subsection-title">8.1 Cap on Liability</h3><p>To the maximum extent permitted by law, SyloraQ's total aggregate liability under this Agreement shall not exceed USD $0. Where applicable law prohibits full exclusion of liability, the minimum liability permitted by such law applies.</p></div><div class="subsection"><h3 class="subsection-title">8.2 Excluded Damages</h3><p>In no event shall SyloraQ be liable for indirect, incidental, special, consequential, punitive, or exemplary damages, including lost profits, loss of business, or loss of data.</p></div><div class="subsection"><h3 class="subsection-title">8.3 Third-Party & Downstream Harm</h3><p>SyloraQ is not liable for any harm caused by Derivative Programs or by actions of downstream users.</p></div></section><section id="indemnification" class="section"><h2 class="section-title"><span class="section-number">9</span>INDEMNIFICATION</h2><div class="subsection"><h3 class="subsection-title">9.1 By Licensee</h3><p>Licensee shall indemnify, defend and hold SyloraQ and its officers, directors, employees and agents harmless from and against all claims, liabilities, damages, losses and expenses (including reasonable attorneys' fees) arising from:</p><ul><li>Licensee's use, distribution, or deployment of the Software or any Derivative Program;</li><li>Any breach by Licensee of this Agreement (including failure to propagate and enforce Sections 3â€“6 and 11);</li><li>Any Malicious Use by Licensee or by any downstream user of Licensee's Derivative Program.</li></ul></div><div class="subsection"><h3 class="subsection-title">9.2 Chain Indemnity</h3><p>Each Immediate Creator of a Derivative Program agrees to indemnify upstream authors and SyloraQ for claims arising from actions of their downstream users where the downstream actions arise from the Immediate Creator's violation or failure to enforce the license obligations.</p></div></section><section id="termination" class="section"><h2 class="section-title"><span class="section-number">10</span>TERMINATION & CONDITIONAL PROTECTION REVOCATION</h2><div class="subsection"><h3 class="subsection-title">10.1 Automatic Termination for Breach</h3><p>Licensee's rights terminate automatically upon any material breach of this Agreement (including Malicious Use). Termination does not affect any accrued rights or obligations.</p></div><div class="critical-box"><strong>10.2 Conditional Protection Revocation:</strong>If any Program or Derivative Program is used, directly or indirectly, to create or distribute malicious software or otherwise engage in Malicious Use:<br>a. That Program and its Immediate Creator(s) lose all protections granted by this Agreement immediately;<br>b. All downstream Derivative Programs that are derived from the violating Program (at any depth) also lose protection automatically;<br>c. Any distribution, hosting, or sale of such violating Programs or their derivatives is a material breach and subjects the Immediate Creator to legal and equitable remedies, including injunctive relief and damages.</div><div class="subsection"><h3 class="subsection-title">10.3 Notice & Cure</h3><p>For non-Malicious breaches, SyloraQ may deliver written notice specifying the breach and a reasonable cure period (if feasible). For Malicious Use, no cure period is required and protection revocation is immediate.</p></div><div class="subsection"><h3 class="subsection-title">10.4 Obligations on Termination</h3><p>Upon termination or revocation of protection, Licensee must:</p><ul><li>Immediately cease all use of the Software and affected Derivative Programs;</li><li>Delete and destroy all copies, distributions, containers, and artifacts containing the Software or Derivative Programs under Licensee's control;</li><li>Provide written certification of deletion and cessation within seven (7) days of request.</li></ul></div><div class="subsection"><h3 class="subsection-title">10.5 Public Notice of Revocation</h3><p>SyloraQ may publicly declare that a Program and its derivatives are no longer protected, and Licensee must include a clear visible notice in any affected program UI, documentation, or distribution channels indicating loss of SyloraQ protection.</p></div></section><section id="chain-protection" class="section"><h2 class="section-title"><span class="section-number">11</span>CHAIN-PROTECTION, PROPAGATION & ENFORCEMENT</h2><div class="code-block">Protection Chain Flow Example: SyloraQ | /|\---------------------\ | | | ProgramA ProgramB ProgramC | | | | | \--> ProgramC6 (HARMFUL) | | --> ProgramC7, ProgramC8 (lose protection) | | ProgramA1 ProgramB1 If any Program becomes malicious, it and ALL downstream derivatives lose protection immediately.</div><div class="subsection"><h3 class="subsection-title">11.1 Propagation Requirement</h3><p>Every Derivative Program must include the full text of this Agreement (or an unalterable machine-readable reference to it) and must present a terms notice to immediate downstream users that includes: (a) the Malicious Use prohibitions; (b) required attribution; (c) the liability and indemnity provisions; and (d) the conditional protection rules (Section 10).</p></div><div class="subsection"><h3 class="subsection-title">11.2 Downstream Enforcement</h3><p>Each Immediate Creator must contractually bind their downstream users to the same obligations and propagation requirements. Licensee must implement reasonable technical and administrative controls to enforce restrictions (e.g., EULA acceptance, API keys with terms, package manifest warnings).</p></div><div class="subsection"><h3 class="subsection-title">11.3 Protection While Compliant</h3><p>Upstream developers (including SyloraQ and any non-violating Immediate Creator) are protected from liability for wrongful acts of downstream users<strong>so long as</strong>they have:</p><ul><li>Complied with propagation obligations;</li><li>Notified downstream users of prohibitions and liability allocations;</li><li>Taken reasonable steps to respond to known violations (e.g., revocation of keys, takedown requests).</li></ul></div><div class="subsection"><h3 class="subsection-title">11.4 Effective Depth & Unlimited Chain</h3><p>These propagation and protection rules apply at unlimited depth: any Program distributed within the Protected Chain must continue the propagation obligations to preserve protection for upstream participants.</p></div><div class="subsection"><h3 class="subsection-title">11.5 Exception for Authorized Security Research</h3><p>If Licensee wishes to perform security research that could produce potentially harmful outputs, Licensee must obtain prior written authorization from SyloraQ and comply with mutually agreed safe-harbor procedures. Unauthorized security research that results in Malicious Use is a Material Breach.</p></div><div class="subsection"><h3 class="subsection-title">11.6 Status Disclosure</h3><p>Any Program that loses protection per Section 10 must clearly and conspicuously disclose its unprotected status to all downstream users and distribution channels.</p></div></section><section id="audits" class="section"><h2 class="section-title"><span class="section-number">12</span>AUDITS & COMPLIANCE CERTIFICATION</h2><div class="subsection"><h3 class="subsection-title">12.1 Audit Rights</h3><p>SyloraQ (or its designated agent) may, with reasonable notice except where Malicious Use is suspected, audit Licensee's compliance with this Agreement (including deployed cloud images, container registries, artifact repositories, and distribution manifests). Licensee must cooperate and provide access to records reasonably required.</p></div><div class="subsection"><h3 class="subsection-title">12.2 Certification</h3><p>Licensee must provide written certification of compliance (format provided by SyloraQ) on reasonable request, including confirmation that: (a) the license text is propagated; (b) attribution is present; (c) measures are in place to prevent Malicious Use.</p></div><div class="subsection"><h3 class="subsection-title">12.3 Remedies</h3><p>Failure to cooperate with audits or to provide certification constitutes a material breach and may result in revocation consistent with Section 10.</p></div></section><section id="privacy" class="section"><h2 class="section-title"><span class="section-number">13</span>DATA PRIVACY & SECURITY OBLIGATIONS</h2><div class="subsection"><h3 class="subsection-title">13.1 No Automatic Data Collection</h3><p>SyloraQ does not automatically collect data from Licensee by reason of distribution of the Software.</p></div><div class="subsection"><h3 class="subsection-title">13.2 Licensee Responsibilities</h3><p>Licensee is responsible for securely handling keys, credentials, and user data. Licensee must implement reasonable administrative, physical, and technical safeguards consistent with industry standards.</p></div><div class="subsection"><h3 class="subsection-title">13.3 Breach Notification</h3><p>Licensee must notify SyloraQ within seventy-two (72) hours of discovering a security incident or personal data breach affecting the Software or Derivative Programs.</p></div></section><section id="export" class="section"><h2 class="section-title"><span class="section-number">14</span>EXPORT CONTROLS & LEGAL COMPLIANCE</h2><div class="subsection"><h3 class="subsection-title">14.1 Export Compliance</h3><p>Licensee shall comply with all applicable export control and sanctions laws and regulations. Licensee shall not export, re-export or transfer the Software to prohibited persons, entities, or locations.</p></div><div class="subsection"><h3 class="subsection-title">14.2 Legal Compliance</h3><p>Licensee must comply with all applicable laws and regulations in its use of the Software.</p></div></section><section id="high-risk" class="section"><h2 class="section-title"><span class="section-number">15</span>HIGH-RISK USE & SAFETY-CRITICAL SYSTEMS</h2><div class="warning-box"><strong>15.1 Not Designed For High-Risk Use:</strong>The Software is not designed or certified for life-critical, safety-critical, medical, aerospace, nuclear, or similarly high-risk systems. Do not use the Software in these environments without prior written agreement from SyloraQ that expressly permits such use and defines additional warranties and liability arrangements.</div></section><section id="severability" class="section"><h2 class="section-title"><span class="section-number">16</span>SEVERABILITY & REFORMATION</h2><div class="subsection"><h3 class="subsection-title">16.1 Severability</h3><p>If any provision is held invalid or unenforceable, the remainder of this Agreement remains in effect. The parties shall negotiate in good faith to replace any invalid provision by a valid provision that most closely approximates the economic intent of the invalid provision.</p></div></section><section id="governing-law" class="section"><h2 class="section-title"><span class="section-number">17</span>GOVERNING LAW & DISPUTE RESOLUTION</h2><div class="subsection"><h3 class="subsection-title">17.1 Governing Law</h3><p>This Agreement shall be governed by and construed in accordance with the laws of Switzerland, excluding its conflicts-of-law rules, except where mandatory provisions of another jurisdiction apply.</p></div><div class="subsection"><h3 class="subsection-title">17.2 Arbitration</h3><p>Except for injunctive relief and urgent equitable remedies, disputes arising out of this Agreement shall be finally resolved by binding arbitration administered by the International Chamber of Commerce (ICC) in English. The seat of arbitration shall be a neutral location agreed by the parties; absent agreement, the seat shall be Geneva, Switzerland.</p></div><div class="subsection"><h3 class="subsection-title">17.3 Injunctive Relief</h3><p>SyloraQ may seek injunctive or other equitable relief in competent courts of any jurisdiction to restrain breaches (including Malicious Use) and to enforce takedowns or revocation notices.</p></div></section><section id="notices" class="section"><h2 class="section-title"><span class="section-number">18</span>NOTICES</h2><div class="subsection"><h3 class="subsection-title">18.1 Notices</h3><p>Any legal notices required under this Agreement shall be in writing and sent to the addresses provided by the parties. Electronic notice (email) is effective if receipt is confirmed or not denied within 48 hours.</p></div></section><section id="signature" class="section"><h2 class="section-title"><span class="section-number">19</span>SIGNATURE</h2><div class="warning-box"><strong>By using, distributing, embedding, or otherwise employing the Software or any Derivative Program, Licensee accepts and agrees to all terms of this Agreement.</strong></div></section><section class="section"><h2 class="section-title"><span class="section-number">âœ“</span>SYLORAQ DEVELOPER CHECKLIST</h2><p style="margin-bottom:2rem">Use this checklist when building or distributing Derivative Programs to ensure you preserve chain protection and comply with SyloraQ license obligations.</p><div class="checklist"><div class="checklist-item"><div class="checkbox">âœ“</div><span><strong>Include LICENSE:</strong>Ensure the full SyloraQ Software License Agreement (2025) is bundled with any distributed artifact (binary, container image, package).</span></div><div class="checklist-item"><div class="checkbox">âœ“</div><span><strong>Attribution:</strong>Display attribution prominently (UI footer, About page, README) with the required statement.</span></div><div class="checklist-item"><div class="checkbox">âœ“</div><span><strong>EULA/Terms for End Users:</strong>Present an End-User License Agreement or Terms that require acceptance before use; include Malicious Use prohibitions and liability allocations.</span></div><div class="checklist-item"><div class="checkbox">âœ“</div><span><strong>Manifest Flag:</strong>Add a machine-readable flag in package manifests (e.g., license_attached: true and syloraq_license_version: "2025-chain-protected").</span></div><div class="checklist-item"><div class="checkbox">âœ“</div><span><strong>API Keys & Access Controls:</strong>If distributing hosted endpoints or SDKs, require API keys or access tokens tied to acceptance of terms; provide revocation mechanisms.</span></div><div class="checklist-item"><div class="checkbox">âœ“</div><span><strong>Audit Trail:</strong>Keep records of distributions, recipient organizations, and proof of license propagation for audits.</span></div><div class="checklist-item"><div class="checkbox">âœ“</div><span><strong>Security Measures:</strong>Implement reasonable security controls (input validation, rate limiting, access control) to reduce misuse risk.</span></div><div class="checklist-item"><div class="checkbox">âœ“</div><span><strong>Incident Response:</strong>Have a plan to respond to reports of abuse (takedown, revoke keys, notify SyloraQ if required).</span></div><div class="checklist-item"><div class="checkbox">âœ“</div><span><strong>Third-Party Notices:</strong>Bundle or reference any third-party licenses included in your artifact.</span></div><div class="checklist-item"><div class="checkbox">âœ“</div><span><strong>Certification:</strong>On request, be prepared to provide a signed compliance certificate to SyloraQ.</span></div></div></section><section class="eula-section"><h2 class="section-title"><span class="section-number">ðŸ“„</span>END-USER LICENSE AGREEMENT (EULA) TEMPLATE</h2><div style="text-align:center;margin-bottom:2rem"><strong>[Your Product Name]</strong><br><em>Effective Date: [Insert Date] | Provider: [Your Company Name]</em></div><div class="subsection"><h3 class="subsection-title">1. Acceptance</h3><p>By installing, copying, or using this product, you agree to be bound by this EULA and by the SyloraQ Software License Agreement (2025). You must read both agreements before use.</p></div><div class="subsection"><h3 class="subsection-title">2. Prohibited Uses</h3><p>You may not use this product to create, distribute, test, or facilitate malware, ransomware, exploits, or any other malicious or illegal software. Such use constitutes a material breach and may result in legal action.</p></div><div class="subsection"><h3 class="subsection-title">3. Attribution</h3><p>This product includes software developed by SyloraQ. The following attribution must be displayed in a prominent location within the product:</p><div class="code-block">"This product uses software developed by SyloraQ Â© 2025."</div></div><div class="subsection"><h3 class="subsection-title">4. Liability</h3><p>You are solely responsible for your actions and any harm caused by software you create or distribute using this product. Upstream developers are not liable for your malicious acts if they have complied with license propagation and enforcement obligations.</p></div><div class="subsection"><h3 class="subsection-title">5. Termination</h3><p>Your rights under this EULA terminate immediately upon breach, including Malicious Use. Upon termination you must cease use and delete all copies of the product.</p></div><div class="subsection"><h3 class="subsection-title">6. Governing Law</h3><p>This EULA is governed by the SyloraQ Software License Agreement and the governing law and dispute resolution provisions therein.</p></div><div class="subsection"><h3 class="subsection-title">7. Acceptance</h3><div style="margin-top:1rem;padding:1rem;background:rgba(0,255,255,.1);border-radius:10px"><input type="checkbox" id="eulaAccept" style="margin-right:.5rem"><label for="eulaAccept">I accept the EULA and the SyloraQ Software License Agreement (2025).</label></div></div></section><section class="section"><div style="text-align:center;font-family:Orbitron,monospace;font-size:1.2rem;padding:2rem"><span style="color:var(--primary-cyan);text-shadow:0 0 10px rgba(0,255,255,.5)">SyloraQ Â© 2025</span></div></section></main><button class="scroll-top" id="scrollTop">â†‘</button><script>
        function updateProgressBar() {
            const winScroll = document.body.scrollTop || document.documentElement.scrollTop;
            const height = document.documentElement.scrollHeight - document.documentElement.clientHeight;
            const scrolled = (winScroll / height) * 100;
            document.getElementById("progressBar").style.width = scrolled + "%";
        }

        window.addEventListener('scroll', updateProgressBar);

        const scrollTopBtn = document.getElementById('scrollTop');
        
        window.addEventListener('scroll', () => {
            if (window.scrollY > 300) {
                scrollTopBtn.classList.add('visible');
            } else {
                scrollTopBtn.classList.remove('visible');
            }
        });

        scrollTopBtn.addEventListener('click', () => {
            window.scrollTo({ top: 0, behavior: 'smooth' });
        });

        document.querySelectorAll('a[href^="#"]').forEach(anchor => {
            anchor.addEventListener('click', function (e) {
                e.preventDefault();
                const target = document.querySelector(this.getAttribute('href'));
                if (target) {
                    target.scrollIntoView({ behavior: 'smooth', block: 'start' });
                }
            });
        });

        document.querySelectorAll('.interactive-definition').forEach(def => {
            def.addEventListener('mouseenter', function() {
                this.style.transform = 'translateX(10px) scale(1.02)';
            });
            
            def.addEventListener('mouseleave', function() {
                this.style.transform = 'translateX(0) scale(1)';
            });
        });

        document.querySelectorAll('.checklist-item').forEach(item => {
            item.addEventListener('click', function() {
                const checkbox = this.querySelector('.checkbox');
                if (checkbox.textContent === 'âœ“') {
                    checkbox.textContent = '';
                    checkbox.style.background = 'transparent';
                } else {
                    checkbox.textContent = 'âœ“';
                    checkbox.style.background = 'var(--primary-purple)';
                }
            });
        });

        const observerOptions = {
            threshold: 0.1,
            rootMargin: '0px 0px -50px 0px'
        };

        const observer = new IntersectionObserver((entries) => {
            entries.forEach(entry => {
                if (entry.isIntersecting) {
                    entry.target.style.opacity = '1';
                    entry.target.style.transform = 'translateY(0)';
                }
            });
        }, observerOptions);

        document.querySelectorAll('.section').forEach(section => {
            section.style.opacity = '0';
            section.style.transform = 'translateY(30px)';
            section.style.transition = 'opacity 0.6s ease, transform 0.6s ease';
            observer.observe(section);
        });

        let particleCount = 0;
        window.addEventListener('scroll', () => {
            if (particleCount < 5 && Math.random() < 0.1) {
                createParticle();
                particleCount++;
                setTimeout(() => particleCount--, 2000);
            }
        });

        function createParticle() {
            const particle = document.createElement('div');
            particle.style.cssText = `
                position: fixed;
                width: 4px;
                height: 4px;
                background: var(--primary-cyan);
                border-radius: 50%;
                pointer-events: none;
                z-index: 1000;
                left: ${Math.random() * window.innerWidth}px;
                top: ${Math.random() * window.innerHeight}px;
                animation: particleFloat 2s ease-out forwards;
            `;
            
            document.body.appendChild(particle);
            
            setTimeout(() => {
                particle.remove();
            }, 2000);
        }

        const style = document.createElement('style');
        style.textContent = `
            @keyframes particleFloat {
                0% {
                    opacity: 1;
                    transform: translateY(0) scale(1);
                }
                100% {
                    opacity: 0;
                    transform: translateY(-100px) scale(0);
                }
            }
        `;
        document.head.appendChild(style);

        const eulaCheckbox = document.getElementById('eulaAccept');
        if (eulaCheckbox) {
            eulaCheckbox.addEventListener('change', function() {
                if (this.checked) {
                    this.parentElement.style.background = 'rgba(139, 92, 246, 0.2)';
                    this.parentElement.style.border = '1px solid var(--primary-purple)';
                } else {
                    this.parentElement.style.background = 'rgba(0, 255, 255, 0.1)';
                    this.parentElement.style.border = 'none';
                }
            });
        }</script></body></html>
